Merck Sharp Dohme BV
General
Total Cases33
Active Cases3
Patents--
--
--
--
Ratings
Experience
Grade
Trend
DCT
L5
A
PTAB
L5
A
CAFC
L4
C
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 07/15/24 | Report to the Commissioner of Patents and Trademarks. (lnb) (Entered: 07/15/2024) | |
| 07/15/24 | SO ORDERED, re 159 Consent Judgment as to Defendant MSN, ***Civil Case Terminated. Signed by Judge Gregory B. Williams on 7/15/2024. (lnb) (Entered: 07/15/2024) | |
| 07/12/24 | PROPOSED CONSENT JUDGMENT by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) (Entered: 07/12/2024) | |
| 06/13/24 | SO ORDERED, re 157 Consent Judgment as to Cipla USA, Inc., and Cipla Limited. Attorney Peter L. Giunta; Matthew B. Goeller; Anil H. Patel; Harold M. Storey; Jenna Bruce and Steven L. Caponi terminated. Signed by Judge Gregory B. Williams on 6/12/2024. (lnb) (Entered: 06/13/2024) | |
| 06/11/24 | PROPOSED CONSENT JUDGMENT as to Defendants Cipla Limited and Cipla USA, Inc. by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) (Entered: 06/11/2024) | |
| 06/05/24 | SO ORDERED, re 155 Consent Judgment -- Party Alembic Pharmaceuticals Limited terminated. Attorneys Jovial Wong; Dominick T. Gattuso and Tyree M. Petty-Williams terminated. Signed by Judge Gregory B. Williams on 6/5/2024. (lnb) (Entered: 06/05/2024) | |
| 05/20/24 | PROPOSED CONSENT JUDGMENT by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Silver, Daniel) (Entered: 05/20/2024) | |
| 05/08/24 | STIPULATION TO EXTEND TIME the Deadline for the Close of Fact Discovery to June 10, 2024 - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) (Entered: 05/08/2024) | |
| 05/08/24 | SO ORDERED- re 154 STIPULATION TO EXTEND TIME the Deadline for the Close of Fact Discovery to June 10, 2024. Set Scheduling Order Deadline: Fact Discovery completed by 6/10/2024. Signed by Judge Sherry R. Fallon on 5/8/2024. (lih) (Entered: 05/08/2024) | |
| 05/07/24 | SO ORDERED, re 153 STIPULATION and Order regarding Infringement and Dismissal of Certain Claims filed by AstraZeneca Pharmaceuticals, LP, Merck Sharp & Dohme B.V., AstraZeneca UK Limited, AstraZeneca AB, Acerta Pharma B.V. Signed by Judge Gregory B. Williams on 5/7/24. (ntl) (Entered: 05/07/2024) |